Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
amag pharmaceuticals
arch venture partners
biotech
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
covis group
3
×
deals
detroit blog main
detroit top stories
duchenne muscular dystrophy
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
investing
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
philadelphia blog main
philadelphia top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
What
bio
3
×
roundup
3
×
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
alliance
bristol
buy
calls
changing
color
crispr
days
growing
hours
kudos
leaves
myers’s
notifying
october
phone
rnai
rouse
scientists
Language
unset
Current search:
roundup
×
" boston blog main "
×
bio
×
" covis group "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More